> top > docs > PubMed:10769629 > annotations

PubMed:10769629 JSONTXT

Annnotations TAB JSON ListView MergeView

PubMed_Structured_Abstracts

Id Subject Object Predicate Lexical cue
T1 151-657 BACKGROUND denotes Protein tyrosine phosphatase gamma (PTP gamma) has been implicated as a potential tumor suppressor gene in kidney and lung adenocarcinomas. We have previously shown that PTP gamma mRNA expression levels are lower in DES-induced kidney tumors than in normal kidneys of Syrian hamsters. The goals of the present study were to determine if PTP gamma mRNA is present in both normal and cancerous human breast cells, and to investigate the estrogenic regulation of PTP gamma mRNA expression in these cell types.
T2 667-1214 METHODS denotes Primary cultured human breast cells derived from surgical specimens of mammoplasty and breast cancer patients, as well as human breast cancer cell lines were used for the study. RT-PCR and RNase protection assay was utilized to detect and quantify levels of PTP gamma mRNA among the cell types used and between control and 17 beta-estradiol (E2)-treated cells. Transient transfection of human estrogen receptor (ER) into MDA-MB-231 human breast cancer cells was performed to establish the role of ER in the regulation of PTP gamma mRNA expression.
T3 1224-2281 RESULTS denotes The results show that PTP gamma mRNA is expressed in primary cultured human breast cells isolated from mammoplasty and breast cancer patients, as well as in human cancer cell lines, and that E2 significantly inhibits PTP gamma expression in ER-positive human breast cancer cells via an ER-mediated mechanism. We show that PTP gamma mRNA levels are lower in human breast cancer cells than in normal human breast cells. Furthermore, we report that PTP gamma mRNA expression is inhibited by E2 in a dose-dependent manner in primary cultured breast cells. After treatment with 20 nM E2 for 24 hours, PTP gamma mRNA was significantly suppressed in primary cultured cancerous and non-cancerous cells from breast cancer patients, as well as in the ER-positive MCF-7 cell line by 50%, 85%, and 66%, respectively. In contrast, the PTP gamma mRNA expression levels did not change in similarly treated ER-negative MDA-MB-231 cells. Sensitivity to E2-induced suppression could be restored (94% inhibition) by transfecting MDA-MB-231 cells with an ER expression plasmid.
T4 2295-2510 CONCLUSIONS denotes Our results are the first to suggest that PTP gamma is a potential estrogen-regulated tumor suppressor gene in human breast cancer which may play an important role in neoplastic processes of human breast epithelium.

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 233-238 HP_0002664 denotes tumor
T2 269-289 HP_0030078 denotes lung adenocarcinomas
T3 386-392 HP_0002664 denotes tumors
T4 533-542 HP_0002664 denotes cancerous

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
10769629-7#241#243#gene2099 1465-1467 gene2099 denotes ER
10769629-7#259#272#diseaseC0006142 1483-1496 diseaseC0006142 denotes breast cancer
241#243#gene2099259#272#diseaseC0006142 10769629-7#241#243#gene2099 10769629-7#259#272#diseaseC0006142 associated_with ER,breast cancer

DisGeNET

Id Subject Object Predicate Lexical cue
T0 42-76 gene:5793 denotes protein tyrosine phosphatase gamma
T1 118-131 disease:C0678222 denotes breast cancer
T2 42-76 gene:5793 denotes protein tyrosine phosphatase gamma
T3 118-131 disease:C0006142 denotes breast cancer
T4 187-190 gene:10076 denotes PTP
T5 274-289 disease:C0001418 denotes adenocarcinomas
T6 187-190 gene:5967 denotes PTP
T7 274-289 disease:C0001418 denotes adenocarcinomas
T8 187-190 gene:5250 denotes PTP
T9 274-289 disease:C0001418 denotes adenocarcinomas
T10 1060-1077 gene:2099 denotes estrogen receptor
T11 1105-1118 disease:C0006142 denotes breast cancer
T12 1060-1077 gene:2099 denotes estrogen receptor
T13 1105-1118 disease:C0678222 denotes breast cancer
T14 1079-1081 gene:2099 denotes ER
T15 1105-1118 disease:C0006142 denotes breast cancer
T16 1079-1081 gene:2099 denotes ER
T17 1105-1118 disease:C0678222 denotes breast cancer
T18 1164-1166 gene:2099 denotes ER
T19 1105-1118 disease:C0006142 denotes breast cancer
T20 1164-1166 gene:2099 denotes ER
T21 1105-1118 disease:C0678222 denotes breast cancer
R1 T0 T1 associated_with protein tyrosine phosphatase gamma,breast cancer
R2 T2 T3 associated_with protein tyrosine phosphatase gamma,breast cancer
R3 T4 T5 associated_with PTP,adenocarcinomas
R4 T6 T7 associated_with PTP,adenocarcinomas
R5 T8 T9 associated_with PTP,adenocarcinomas
R6 T10 T11 associated_with estrogen receptor,breast cancer
R7 T12 T13 associated_with estrogen receptor,breast cancer
R8 T14 T15 associated_with ER,breast cancer
R9 T16 T17 associated_with ER,breast cancer
R10 T18 T19 associated_with ER,breast cancer
R11 T20 T21 associated_with ER,breast cancer